Dimed Distribuidora de Medicamentos (BSP:PNVL3) Owner Earnings per Share (TTM): 1.33 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:PNVL3 Dimed SA Distribuidora de Medicamentos BSP:PNVL3
88 GF Score
Price R$11.94
GF Value R$13.21
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Dimed Distribuidora de Medicamentos Owner Earnings per Share (TTM)?

Dimed Distribuidora de Medicamentos BSP:PNVL3 -0.25% 88 Owner Earnings per Share (TTM) is 1.33 as of Jun. 2026. GuruFocus rates BSP:PNVL3 with a GF Score™ of 88/100 and a GF Value™ of R$13.21 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 463 Drug Manufacturers companies, Dimed Distribuidora de Medicamentos ranks better than 81.64% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Dimed Distribuidora de Medicamentos's Owner Earnings per Share (TTM) ended in Jun. 2026 was R$1.33. It's Price-to-Owner-Earnings ratio for today is 8.98.


The historical rank and industry rank for Dimed Distribuidora de Medicamentos's Owner Earnings per Share (TTM) or its related term are showing as below:

BSP:PNVL3' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.06   Med: 22.26   Max: 8001.67
Current: 8.98


During the past 13 years, the highest Price-to-Owner-Earnings ratio of Dimed Distribuidora de Medicamentos was 8001.67. The lowest was 6.06. And the median was 22.26.


BSP:PNVL3's Price-to-Owner-Earnings is ranked better than
81.64% of 463 companies
in the Drug Manufacturers industry
Industry Median: 23.15 vs BSP:PNVL3: 8.98

Dimed Distribuidora de Medicamentos's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was R$0.00. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was R$0.71. It's PE Ratio (TTM) ratio for today is 16.82.

Dimed Distribuidora de Medicamentos's EPS without NRI for the three months ended in Jun. 2026 was R$0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was R$0.69. It's PE Ratio without NRI ratio for today is 17.35.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Dimed Distribuidora de Medicamentos Owner Earnings per Share (TTM) Related Terms


Dimed Distribuidora de Medicamentos Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for Dimed Distribuidora de Medicamentos's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dimed Distribuidora de Medicamentos Owner Earnings per Share (TTM) Chart

Dimed Distribuidora de Medicamentos Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.55 0.93 0.17 1.85

Dimed Distribuidora de Medicamentos Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.99 1.51 1.85 1.57 1.33

BSP:PNVL3 vs LLY, JNJ, ABBV: Owner Earnings per Share (TTM) Comparison

For the Drug Manufacturers - General subindustry, Dimed Distribuidora de Medicamentos's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dimed Distribuidora de Medicamentos Price-to-Owner-Earnings vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dimed Distribuidora de Medicamentos's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Dimed Distribuidora de Medicamentos's Price-to-Owner-Earnings falls into.


BSP:PNVL3
88GF Score
Dimed SA Distribuidora de Medicamentos BSP:PNVL3
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dimed Distribuidora de Medicamentos Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Dimed Distribuidora de Medicamentos's Owner Earnings per Share (TTM) Calculation:

TTM / Last Quarter Average of Last 20 Quarters
Net Income 138
Depreciation, Depletion and Amortization 242
Change In Deferred Tax 24
5Y Average of Maintenance Capital Expenditure 111
Change In Working Capital -94
Shares Outstanding (Diluted Average) 149

1. Start with "Net Income" from income statement. Dimed Distribuidora de Medicamentos's Net Income for the trailing twelve months (TTM) ended in Jun. 2026 was R$138 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Dimed Distribuidora de Medicamentos's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Jun. 2026 was R$242 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Dimed Distribuidora de Medicamentos's Change In Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2026 was R$24 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = R$111 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous quarter. If the revenue decreased from the previous quarter, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous quarter, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Dimed Distribuidora de Medicamentos's 5-Year Average Maintenance Capital Expenditure = R$111 Mil

5. "Change In Working Capital" is from cashflow statement. Dimed Distribuidora de Medicamentos's Change In Working Capital for the trailing twelve months (TTM) ended in Jun. 2026 was R$-94 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Dimed Distribuidora de Medicamentos's Shares Outstanding (Diluted Average) for the months ended in Jun. 2026 was 149.024 Mil.

Dimed Distribuidora de Medicamentos's Onwer Earnings Per Share for Jun. 2026 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 137.651 +242.115+23.546
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-110.64381365382+-94.472)/149.024
=1.33

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=11.94/1.33
=8.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of 1.33 mean?
Dimed Distribuidora de Medicamentos (BSP:PNVL3) has a Owner Earnings per Share (TTM) of 1.33 as of Jun. 2026. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Dimed Distribuidora de Medicamentos. According to the industry distribution chart, Dimed Distribuidora de Medicamentos ranks #85 out of 463 companies in the Drug Manufacturers industry, placing it in the top 18.4%.
Is Dimed Distribuidora de Medicamentos' Owner Earnings per Share (TTM) too high?
Dimed Distribuidora de Medicamentos' current Owner Earnings per Share (TTM) is 1.33. The Drug Manufacturers industry median Owner Earnings per Share (TTM) is 23.15. Dimed Distribuidora de Medicamentos' value of 1.33 is 94.3% below this industry median. Based on the distribution chart, Dimed Distribuidora de Medicamentos ranks #85 out of 463 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Dimed Distribuidora de Medicamentos has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dimed Distribuidora de Medicamentos' Owner Earnings per Share (TTM) compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Dimed Distribuidora de Medicamentos ranks #85 out of 463 companies for Owner Earnings per Share (TTM). This places Dimed Distribuidora de Medicamentos in the top 18% of its industry — outperforming the majority of peers. The industry median Owner Earnings per Share (TTM) is 23.15. Dimed Distribuidora de Medicamentos' value of 1.33 is 94.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Drug Manufacturers company?
The median Owner Earnings per Share (TTM) among Drug Manufacturers companies is 23.15, based on 463 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dimed Distribuidora de Medicamentos's current Owner Earnings per Share (TTM) of 1.33 is 94.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Dimed Distribuidora de Medicamentos. For the Drug Manufacturers industry, the median Owner Earnings per Share (TTM) is 23.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dimed Distribuidora de Medicamentos's current Owner Earnings per Share (TTM) is 1.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dimed Distribuidora de Medicamentos stock overvalued right now?
Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos (BSP:PNVL3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$13.21, compared to a current price of R$11.94 — trading 9.6% below its estimated fair value. The current Owner Earnings per Share (TTM) is 1.33 and 94.3% below the Drug Manufacturers industry median of 23.15. Dimed Distribuidora de Medicamentos' overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For Dimed Distribuidora de Medicamentos (BSP:PNVL3), the current Owner Earnings per Share (TTM) is 1.33 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dimed Distribuidora de Medicamentos (BSP:PNVL3) Overvalued in 2026?

Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos stock appears to be undervalued. The current stock price of R$11.94 is trading 9.6% below its estimated GF Value™ of R$13.21. GuruFocus considers Dimed Distribuidora de Medicamentos to be Modestly Undervalued.

Key valuation signals for BSP:PNVL3:

  • Owner Earnings per Share (TTM): 1.33
  • GF Value™: R$13.21 vs. price of R$11.94 (9.6% below fair value)
  • GF Score™: 88/100 with 5 warning signs
  • Industry Position: 94.3% below the Drug Manufacturers median (#85 of 463)

No single metric tells the full story. See the BSP:PNVL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dimed Distribuidora de Medicamentos Business Description

Address Avenida Industrial Belgraf, 865, Eldorado do Sul, RS, BRA, 92990-000
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. It has single reportable segment that is, The Retail segment. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.
88GF Score

Get the complete analysis for BSP:PNVL3

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$11.94
Price
R$13.21
GF Value